| 臺大學術典藏 |
2021-01-05T02:28:56Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Lee H.; Che M.-I.; Jeng Y.-M.; Ho W.-L.; Hung J.-S.; Huang J.; Wang W.-J.; Chen Y.-H.; Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Lu M.-Y.; Yang Y.-L.; SHIANN-TANG JOU; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Huang M.-C. |
| 臺大學術典藏 |
2020-12-28T06:25:51Z |
Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer
|
Li Y.-I.; Liang J.-T.; Li H.-Y.; Su C.-Y.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; HSIEN-LI KAO; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S. |
| 臺大學術典藏 |
2020-12-18T05:28:43Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Huang M.-C.; Lee H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; HSIU-HAO CHANG |
| 臺大學術典藏 |
2020-12-16T07:21:56Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; Lee H.; MENG-YAO LU; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Huang M.-C. |
| 臺大學術典藏 |
2020-11-19T03:20:01Z |
Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
|
Hung J.-S.; Chang M.-C.; PO-HUANG LEE; Tien Y.-W. |
| 臺大學術典藏 |
2020-11-19T03:20:00Z |
Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy
|
PO-HUANG LEE; Wang H.-P.; Hung J.-S.; Hu R.-H.; Tien Y.-W. |
| 臺大學術典藏 |
2020-11-19T03:19:28Z |
The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK
|
Huang J.; Che M.-I.; Lin N.-Y.; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; PO-HUANG LEE; Liang J.-T.; Huang M.-C. |
| 臺大學術典藏 |
2020-11-19T03:19:27Z |
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying o-glycosylation of FGFR2
|
Huang M.-C.; Liang J.-T.; Lai H.-S.; PO-HUANG LEE; Huang M.-J.; Lin Y.-C.; Hung J.-S.; Huang J. |
| 臺大學術典藏 |
2020-09-29T07:28:01Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Po-Chu Lee;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Hung J.-S.;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Huang M.-C.; PO-CHU LEE; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. |
| 臺大學術典藏 |
2020-06-16T07:53:31Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-06-01T06:31:32Z |
Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer
|
Li Y.-I.;Hung J.-S.;Yu T.-Y.;Liou J.-M.;Wei J.-N.;Kao H.-L.;Chuang L.-M.;Shun C.-T.;Lee P.-H.;Lai H.-S.;Su C.-Y.;Hung-Yuan Li;Liang J.-T.; Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; HUNG-YUAN LI; Liang J.-T. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-07T06:56:25Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:18Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:10Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; YUNG-MING JENG; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Huang M.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:20Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:12Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:09Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:46Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T06:28:43Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R. |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T03:20:18Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; WEN-MING HSU; Huang M.-C. |
| 臺大學術典藏 |
2020-03-05T03:20:15Z |
β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
|
Che M.-I.;Huang J.;Hung J.-S.;Lin Y.-C.;Huang M.-J.;Lai H.-S.;Wen-Ming Hsu;Liang J.-T.;Huang M.-C.; Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; Lai H.-S.; WEN-MING HSU; Liang J.-T.; Huang M.-C. |
| 臺大學術典藏 |
2020-03-02T06:30:11Z |
The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK
|
Huang J.; Che M.-I.; NENG-YU LIN; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; Lee P.-H.; Liang J.-T.; Huang M.-C. |
| 臺大學術典藏 |
2020-03-02T06:05:28Z |
COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2
|
Lee J.-J.; Chen C.-H.; Chen Y.-H.; Huang M.-J.; Huang J.; Hung J.-S.; Chen M.-T.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:26Z |
β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma
|
Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:26Z |
MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer
|
MIN-CHUAN HUANG; Chen C.-H.; Wang S.-W.; Chen C.-W.; Huang M.-R.; Hung J.-S.; Huang H.-C.; Lin H.-H.; Chen R.-J.; Shyu M.-K. |
| 臺大學術典藏 |
2020-03-02T06:05:24Z |
β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer
|
Chen C.-H.; Wang S.-H.; Liu C.-H.; Wu Y.-L.; Wang W.-J.; Huang J.; Hung J.-S.; Lai I.-R.; Liang J.-T.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:24Z |
The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK
|
Huang J.; Che M.-I.; Lin N.-Y.; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; Lee P.-H.; Liang J.-T.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:23Z |
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying o-glycosylation of FGFR2
|
Hung J.-S.; Huang J.; Lin Y.-C.; Huang M.-J.; Lee P.-H.; Lai H.-S.; Liang J.-T.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:23Z |
β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
|
Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; Lai H.-S.; Hsu W.-M.; Liang J.-T.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:22Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:21Z |
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway
|
Chou C.-H.; Huang M.-J.; Chen C.-H.; Shyu M.-K.; Huang J.; Hung J.-S.; Huang C.-S.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:15Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Hung J.-S.;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Min-Chuan Huang; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-02-24T05:13:13Z |
β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
|
Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; HONG-SHIEE LAI; Hsu W.-M.; Liang J.-T.; Huang M.-C. |
| 臺大學術典藏 |
2020-02-24T05:13:11Z |
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying o-glycosylation of FGFR2
|
Hung J.-S.; Huang J.; Lin Y.-C.; Huang M.-J.; Lee P.-H.; HONG-SHIEE LAI; Liang J.-T.; Huang M.-C. |
| 臺大學術典藏 |
2020-02-24T05:13:08Z |
Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer
|
Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; HONG-SHIEE LAI; Su C.-Y.; Li H.-Y.; Liang J.-T. |
| 臺大學術典藏 |
2020-02-24T02:29:12Z |
Long-term follow-up for patients with colonic perforation due to colonoscopy: From clinical and medicolegal viewpoints
|
Chen T.-C.;Hung J.-S.;Been-Ren Lin;Huang J.;Liang J.-T.; Chen T.-C.; Hung J.-S.; BEEN-REN LIN; Huang J.; Liang J.-T. |
| 臺大學術典藏 |
2020-02-24T01:34:00Z |
Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy
|
Lee P.-H.;Wang H.-P.;Hung J.-S.;REY-HENG HU;Tien Y.-W.; Tien Y.-W.; REY-HENG HU; Hung J.-S.; Wang H.-P.; Lee P.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:18Z |
Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy
|
Yu-Wen Tien;Hu R.-H.;Hung J.-S.;Wang H.-P.;Lee P.-H.; YU-WEN TIEN; Hu R.-H.; Hung J.-S.; Wang H.-P.; Lee P.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:18Z |
Surgical treatment of pancreatic serous cystadenoma: Aggressive for operations but limited resections
|
YU-WEN TIEN;Lee P.-H.;Hu R.-H.;Yang C.-Y.;Hung J.-S.; Hung J.-S.; Yang C.-Y.; Hu R.-H.; Lee P.-H.; YU-WEN TIEN |
| 臺大學術典藏 |
2020-02-20T06:53:18Z |
Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
|
Hung J.-S.;Chang M.-C.;Lee P.-H.;Yu-Wen Tien; Hung J.-S.; Chang M.-C.; Lee P.-H.; YU-WEN TIEN |
| 臺大學術典藏 |
2020-02-17T08:50:56Z |
MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer
|
Chen C.-H; Wang S.-W; Chen C.-W; Huang M.-R; Hung J.-S; Huang H.-C; HO-HSIUNG LIN; Chen R.-J; Shyu M.-K; Huang M.-C. |
